Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jan-Dec:14:21501319231210619.
doi: 10.1177/21501319231210619.

Effectiveness of Program to Slow Progression of Chronic Kidney Disease Among T2DM With HT With CKD 3 in the Community: A Randomized Controlled Trial

Jiraporn Suvamat  1 , Arpaporn Powwattana  1 , Weena Thaingtham  1 , Panan Pichayapinyo  1 , Surapon Boonlue  2
Affiliations
Randomized Controlled Trial

Effectiveness of Program to Slow Progression of Chronic Kidney Disease Among T2DM With HT With CKD 3 in the Community: A Randomized Controlled Trial

Jiraporn Suvamat et al. J Prim Care Community Health. 2023 Jan-Dec.

Abstract

Chronic kidney disease (CKD) is a significant threat to the quality of life of the global population. Thus, slowing kidney disease progression is considered vital in the treatment of CKD patients. The study aimed to evaluate the effectiveness of a program designed to slow the progression of CKD among Type 2 diabetes mellitus patients with HT with stage 3 CKD (CKD 3) in Thailand by adopting the information-motivation-behavioral skills (IMB) model and applying technology. This study was conducted as a cluster randomized controlled trial. The program activities comprised: (i) providing disease information and teaching behaviors to slow the progression of kidney disease to patients and family members via a 2-h session; (ii) teaching practical behavioral skills for appropriate diet and exercise to patients and family members via a 2-h session; (iii) enhancing personal motivation via the Line application and motivational interviewing via telephone calls; (iv) enhancing social motivation with the support of a family member; (v) employing technology to monitor behaviors and increase patient motivation; and (vi) assessing behaviors that were not practical, exploring barriers to behavior modification, and teaching further practical behavioral skills via the Line application. The data were analyzed using percentages, means, standard deviations, chi-square tests, t-tests, and a 2-way repeated-measures analysis of variance. The results showed that after the experiment, the experimental group had significantly higher mean scores in terms of knowledge, perceived benefits, perceived severity, self-efficacy, and behaviors to slow the progression of kidney disease than the control group (P < .05). Further, the experimental group had significantly better clinical outcomes (SBP, DBP, eGFR, BUN, creatinine, albuminuria, FBS, and HbA1c) than the control group (P < .05). In summary, the findings indicate that the program improved clinical outcomes, especially kidney function, effectively slowing the progression of kidney disease.

Keywords: CKD stage 3; risk factors modification; slow progression of kidney disease; the information–motivation–behavioral skills model.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flow diagrams of a comparison between the experimental group and the comparison group in program implementation.
See this image and copyright information in PMC

References

    1. Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. doi: 10.1016/s0140-6736(20)30045-3 - DOI - PMC - PubMed
    1. Bahareh G, Sarokhani D, Ali Hasanpour D, Kourosh S, Mohammad HH. Quality of Life of patients with chronic kidney disease in Iran: systematic review and meta-analysis. Indian J Palliat Care. 2018;24(1):104. doi: 10.4103/IJPC.IJPC_146_17 - DOI - PMC - PubMed
    1. Filgueiras de, Assis MV, Angelo M. The impact of chronic kidney disease: experiences of patients and relatives from the extreme north of Brazil. Investig Educ Enferm. 2018;36(1): e02. doi: 10.17533/udea.iee.v36n1e02 - DOI - PubMed
    1. KanKarn W, Damnok K, Anutrakulchai S. Effectiveness of care model for chronic kidney disease patients using integrated disease management and case management in primary care units, Northeast. J Nurs Health Care. 2019; 37(3):173-182.
    1. Taweebut P, Kerdmongkol P, Amnatsatsue K. The effective of a supportive-educative nursing program for chronic disease patients with early stage kidney disease. J Public Health Nurs. 2017;31(1):129-145.

Publication types

MeSH terms

Associated data